Editorial
doi: 10.1016/s0213-9111(07)71961-1.
[The financing and price regulation of drugs in the Spanish National Health System: changes and continuity]
[Article in
Spanish]
- PMID: 17306178
- DOI: 10.1016/s0213-9111(07)71961-1
Item in Clipboard
Editorial
[The financing and price regulation of drugs in the Spanish National Health System: changes and continuity]
[Article in
Spanish]
Gac Sanit.
2007 Jan-Feb.
Free article
No abstract available
Similar articles
-
Reanalyzing reverse payment settlements: a solution to the patentee's dilemma.Cornell Law Rev. 2014 Jul;99(5):1227-58. Cornell Law Rev. 2014. PMID: 25112001 No abstract available.
-
New prescription for the Spanish drug sector: fighting against public deficit without wasting ammunition.Pharmacoeconomics. 2010;28(11):977-80. doi: 10.2165/11535780-000000000-00000. Pharmacoeconomics. 2010. PMID: 20936881 No abstract available.
-
Generic drugs: the stalling game.Consum Rep. 2001 Jul;66(7):36-40. Consum Rep. 2001. PMID: 11725791
-
[Regulation about generics approval].Farm Hosp. 2006 Nov-Dec;30(6):379-84. doi: 10.1016/s1130-6343(06)74010-7. Farm Hosp. 2006. PMID: 17298196 Review. Spanish.
-
[Drugs in the European Union: the health-market complex].Gac Sanit. 2005 Mar-Apr;19(2):151-67. doi: 10.1157/13074370. Gac Sanit. 2005. PMID: 15860163 Review. Spanish.
Cited by
-
Are prescribing doctors sensitive to the price that their patients have to pay in the Spanish National Health System?BMC Health Serv Res. 2011 Dec 8;11:333. doi: 10.1186/1472-6963-11-333. BMC Health Serv Res. 2011. PMID: 22151628 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
